Loading video...
Video Failed to Load
GI Pathology 101! For each subsite, we go through path basics – histology, IHC & molecular markers, key features from resection specimen & more. I ask Suntrea Hammer to explain path slides to me like I’m a 5-year-old 😀 Here's Part 1: CRC Full video link & slides below🧵1/4:
13,702 views • 1 year ago •via X (Twitter)
8 Comments

YouTube link 2/4:

Slides 3/4:

Mores slides 4/4. Though much more helpful to listen to Suntrea explain the histo: Other subsites coming soon, let me know any feedback.

Dr. Sanford, your approach to breaking down GI pathology is highly commendable! Understanding histology, IHC, and molecular markers is crucial for accurate diagnosis and treatment planning. A question for @SuntreaHammer: what do you consider the most challenging aspect when explaining molecular markers to a non-specialist? For anyone interested in deepening their knowledge or seeking more detailed reviews on topics like these, I recommend It’s a one-stop platform answering every biomedical question and generating comprehensive reviews. #Medicine #Gastroenterology

❓Adjuvant/perioperative chemotherapy for curative liver metastesectomy of CRC? @myESMO #ESMOGI25 ✅Probably DFS but no OS benefit ✅decision should be individualized ❓ctDNA? 👉 #cancer #oncology #MedX #CRC @OncoAlert @realbowtiedoc

🆕 Final analysis of SURF-RCT/SURF-Cohort for small HCC just dropped in @JCO_ASCO: surgery vs RFA ⚔️ 🎯 5-yr OS: 74.6% (S) vs 70.4% (RFA) 🎯 5-yr RFS: 42.9% (S) vs 42.7% (RFA) 💥 AEs: 3.3% (S) vs 0% (RFA) Sometimes, less is more — and the probe wins again ⚖️ Congrats to @YoKawaguchiUT and all the team! 👏🏼 @OncoAlert #OncoAlertAF @_SEOM @GrupoTTD

I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference! Dr. Marina Garassino @marinagarassino joins with the latest updates in immunotherapy for NSCLC. Register today!
